Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
作者： Anne Marie Lennon , Adam H. Buchanan , Isaac Kinde , Andrew Warren , Ashley Honushefsky
关键词: Positron Emission Tomography-Computed Tomography 、 Hematologic tests 、 Blood testing 、 Clinical care 、 Radiology 、 Cohort study 、 Cancer 、 Medicine 、 PET-CT 、 Disease
摘要: … We performed an exploratory prospective, interventional study, called DETECT-A (Detecting … IK, and CL are founders of and hold equity in Thrive Earlier Detection. KWK, NP, and CL are …
sciencemag.org
elsevier.com参考文章(50)
Irina Sachelarie, Karolyn Kerr, Ronald H. Blum, Munir Ghesani, Integrated PET-CT: evidence-based review of oncology indications. Oncology. ,vol. 19, pp. 481- 490 ,(2005)
, Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. ,vol. 365, pp. 395- 409 ,(2011) , 10.1056/NEJMOA1102873
Mithat Gönen, Heiko Schöder, Screening for Cancer with PET and PET/CT: Potential and Limitations The Journal of Nuclear Medicine. ,vol. 48, pp. 4- 18 ,(2007)
Thierry André, Armand De Gramont, Dewi Vernerey, Benoist Chibaudel, Franck Bonnetain, Annemilaï Tijeras-Raballand, Aurelie Scriva, Tamas Hickish, Josep Tabernero, Jean Luc Van Laethem, Maria Banzi, Eduard Maartense, Einat Shmueli, Goran U Carlsson, Werner Scheithauer, Demetris Papamichael, Marcus Möehler, Stefania Landolfi, Pieter Demetter, Soudhir Colote, Christophe Tournigand, Christophe Louvet, Alex Duval, Jean-François Fléjou, Aimery de Gramont, None, Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study Journal of Clinical Oncology. ,vol. 33, pp. 4176- 4187 ,(2015) , 10.1200/JCO.2015.63.4238
Koji Tamakoshi, Fumitaka Kikkawa, Kiyosumi Shibata, Kiyoshi Tomoda, Naoko H. Obata, Fumiyo Wakahara, Yahito Tokuhashi, Hisatake Ishikawa, Michiyasu Kawai, Yutaka Tomoda, Clinical Value of CA125, CA19-9, CEA, CA72-4, and TPA in Borderline Ovarian Tumor Gynecologic Oncology. ,vol. 62, pp. 67- 72 ,(1996) , 10.1006/GYNO.1996.0191
Mary E. Charlson, Peter Pompei, Kathy L. Ales, C.Ronald MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation☆ Journal of Chronic Diseases. ,vol. 40, pp. 373- 383 ,(1987) , 10.1016/0021-9681(87)90171-8
F. Diehl, M. Li, D. Dressman, Y. He, D. Shen, S. Szabo, L. A. Diaz, S. N. Goodman, K. A. David, H. Juhl, K. W. Kinzler, B. Vogelstein, Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 16368- 16373 ,(2005) , 10.1073/PNAS.0507904102
Luis A. Diaz, Alberto Bardelli, Liquid Biopsies: Genotyping Circulating Tumor DNA Journal of Clinical Oncology. ,vol. 32, pp. 579- 586 ,(2014) , 10.1200/JCO.2012.45.2011
Laszlo Tabar, Gunnar Fagerberg, Hsiu-Hsi Chen, Stephen W. Duffy, Charles R. Smart, Adel Gad, Robert A. Smith, Efficacy of breast cancer screening by age. New results swedish two-county trial Cancer. ,vol. 75, pp. 2507- 2517 ,(1995) , 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H
Miguel J. Divo, Carlos H. Martinez, David M. Mannino, Ageing and the epidemiology of multimorbidity European Respiratory Journal. ,vol. 44, pp. 1055- 1068 ,(2014) , 10.1183/09031936.00059814